Kowalski A, Lefèvre J P, Nowak P. "一种的合成方法" [P]. European Patent, EP 3188210 A1, 2016-12-25.
O'Brien P Q, Park J H, Yamamoto T. "Method for the Synthesis of (2-Methyl-1h-indol-5-yl)methanamine hydrochloride" [P]. US Patent, US 9767417 B2, 2022-07-25.
发明人沈红梅,刘建华,徐明华. "A Process for Preparing High-Purity (2-Methyl-1h-indol-5-yl)methanamine hydrochloride" [P]. 中国发明专利, 专利号 CN 108531562 A, 授权公告日 2015-11-15.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2021, 127, (12), 6716-6722.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2010, 1546, (10), 8969-8978.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of (2-Methyl-1h-indol-5-yl)methanamine hydrochloride Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2011, 1896, 4305-4318.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2013, 1933, (5), 2977-2993.